Medication Guide - 11/19/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Keytruda Pembrolizumab SOLUTION;INTRAVENOUS 125514 MERCK SHARP DOHME 11/17/2021 Ruxience Rituximab-Pvvr INJECTABLE;INJECTION 761103 PFIZER INC 11/15/2021 Besremi Ropeginterferon Alfa-2b-Njft INJECTABLE;SUBCUTANEOUS 761166 PHARMAESSENTIA CORP 11/12/2021 Lupron Depot-Ped Kit Leuprolide Acetate POWDER;INTRAMUSCULAR 020263 ABBVIE ENDOCRINE INC 11/12/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA